AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2010
Jun 8, 2010
30583_dirs_2010-06-08_7cdf528a-32d8-4347-aadd-ccf77a816315.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2010-05-22
Reporting Person: ASELAGE STEVE (EVP, Chief Business Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-05-22 | Common Stock | M | 2500 | — | Acquired | 35087 | Direct |
| 2010-06-07 | Common Stock | M | 2500 | — | Acquired | 37587 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-05-22 | Restricted Stock Units | $0 | M | 2500 | Disposed | Common Stock (2500) | Direct | |
| 2010-06-07 | Restricted Stock Units | $0 | M | 2500 | Disposed | Common Stock (2500) | Direct |
Footnotes
F1: Represents restricted stock units which automatically converted to common stock upon the vesting of such units on a one-to-one basis, pursuant to restricted stock units granted May 22, 2008.
F2: Represents restricted stock units which automatically converted to common stock upon the vesting of such units on a one-to-one basis, pursuant to restricted stock units granted June 7, 2007.
F3: Original grant of restricted stock units vest 1/4th each on June 22, 2009, May 22, 2010, May 22, 2011 and May 22, 2012.
F4: Original grant of restricted stock units vest 1/4th each on July 7, 2008, June 7, 2009, June 7, 2010 and June 7, 2011.